Follow The Filings

ABCL AbCellera Biologics

AbCellera Biologics earnings company data as of 4:46 AM ET 11/1

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS -0.18 — —
Rev $6.2M — —

Insider trades

Open-market buys and sales by ABCL's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ABCL insider trades
  • $2.7M bought by 4 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Michael R Hayden Director
    Buy
    $570K 53,613 shares at $10.64 +4.1% to stake
    Traded Aug 24 Filed Aug 24
  2. John S. Montalbano Director
    Buy
    $110K 10,000 shares at $11.03 +4.1% to stake
    Traded Aug 18 Filed Aug 18
  3. Andrew Booth CFO
    Buy
    $384K 37,200 shares at $10.32 +8.3% to stake
    Traded Aug 14 Filed Aug 14
  4. Michael R Hayden Director
    Buy
    $481K 46,387 shares at $10.37 +3.6% to stake
    Traded Aug 12 Filed Aug 14
  5. John S. Montalbano Director
    Buy
    $95K 20,000 shares at $4.77 +9% to stake
    Traded May 14 Filed May 18
  6. Thermopylae Holdings Ltd. 10% owner
    Buy
    $131K 38,000 shares at $3.44 +0.1% to stake
    Traded Feb 27 Filed Mar 2
  7. Thermopylae Holdings Ltd. 10% owner
    Buy
    $580K 177,457 shares at $3.27 +0.3% to stake
    Traded Feb 26 Filed Feb 27
  8. Andrew Booth CFO
    Buy
    $146K 42,600 shares at $3.42 +28% to stake
    Traded Feb 27 Filed Feb 27
  9. John S. Montalbano Director
    Buy
    $178K 50,000 shares at $3.57 +29% to stake
    Traded Nov 26, 2025 Filed Nov 26, 2025

Also filed in the last 12 months, not counted as buying or selling: 2 gifts and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 20 shown.

Filed Form Detail Links
424B5
8-K 1.01,8.01,9.01
424B5
8-K 7.01,9.01
8-K 8.01,9.01
8-K 2.02,7.01,9.01
10-Q
8-K 8.01,9.01
8-K 5.02,9.01
8-K 8.01,9.01
8-K 5.07
8-K 5.02,9.01
8-K 2.02,7.01,9.01
10-Q
SCHEDULE 13G/A —
DEF 14A
DEFA14A
8-K 2.02,7.01,9.01
10-K
8-K 7.01,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf